Evgeniya A. Sokolova
16/10 Miklukho Maklay St
Moscow, MOW 117997, Russian Federation
Moscow, MOW 117997, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
UCNP-based Photoluminescent Nanomedicines for Targeted Imaging and Theranostics of Cancer.
Journal: Molecules (Basel, Switzerland)
Published: August 15, 2020
HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model.
Journal: International journal of molecular sciences
Published: April 08, 2019
Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin.
Journal: Pharmaceutics
Published: March 28, 2019
Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency.
Journal: Cancers
Published: November 26, 2018
3D in vitro models of tumors expressing EGFR family receptors: a potent tool for studying receptor biology and targeted drug development.
Journal: Drug discovery today
Published: May 08, 2018
HER2-specific recombinant immunotoxin 4D5scFv-PE40 passes through retrograde trafficking route and forces cells to enter apoptosis.
Journal: Oncotarget
Published: September 23, 2016
Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 17, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026